DL-Carbidopa
| Product Name | DL-Carbidopa |
|---|---|
| Alternate Names | Carbidopa Impurities, Impurities of Carbidopa |
| CAT No. | CS-T-50252 |
| CAS No. | 302-53-4 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 226.23 g/mol |
| Mol. For. | C₁₀H₁₄N₂O₄ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Carbidopa |
| Therapeutic | Anti-Parkinsons |
| Canonical Smiles | CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN |
| InchIKey | TZFNLOMSOLWIDK-UHFFFAOYSA-N |
| Inchl | InChI=1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16) |
| IUPAC | 3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
DL-Carbidopa is a drug that is commonly used in the treatment of Parkinson's disease. It is a chemical compound that is structurally similar to the amino acid tyrosine. DL-Carbidopa works by inhibiting the activity of the enzyme DOPA decarboxylase, which is responsible for the breakdown of levodopa in the peripheral nervous system. This results in increased levels of levodopa in the brain, which improves the symptoms of Parkinson's disease.
DL-Carbidopa is typically administered orally in combination with levodopa. This combination is known as carbidopa-levodopa or Sinemet. DL-Carbidopa is not effective on its own and must be used in combination with levodopa to be effective.
The chemical formula of DL-Carbidopa is C10H14N2O4. It is a white, crystalline powder that is soluble in water. The drug is typically available in tablet form and is taken orally.
DL-Carbidopa is generally well-tolerated, but like any medication, it can cause side effects. The most common side effects of DL-Carbidopa include nausea, vomiting, loss of appetite, and diarrhea. In rare cases, DL-Carbidopa can cause more serious side effects such as hallucinations, confusion, and difficulty breathing. It is important to talk to a healthcare provider if you experience any side effects while taking DL-Carbidopa.
Get an Instant Quote
Related Compounds
Carbidopa Methyl Ester | Carbidopa monohydrate | Carbidopa EP Impurity C | Carbidopa EP Impurity I (Racemic) | Carbidopa Imine ester | Carbidopa EP Impurity E | Carbidopa EP Impurity F | Carbidopa EP Impurity J | Carbidopa EP Impurity B | N-NITROSO CARBIDOPA | Carbidopa Ethyl Ester Hydrochloride |